Seeking Alpha

Allergan (AGN): Q3 EPS of $0.92 beats by $0.02. Revenue of $1.33B in-line. Sees Q4 EPS of...

Allergan (AGN): Q3 EPS of $0.92 beats by $0.02. Revenue of $1.33B in-line. Sees Q4 EPS of $0.97-0.99 vs $1.01 consensus. Shares -2.2% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)